88919-22-6,
3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide,
1-(3-(2-Aminoethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide,
Didesmethyl sumatriptan,
UNII-WE0Q003U63,
1-[3-(2-aminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide,
1H-Indole-5-methanesulfonamide, 3-(2-aminoethyl)-N-methyl-,
WE0Q003U63,
AK-46651,
(3-(2-Aminoethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide,
1H-Indole-5-methanesulfonamide,3-(2-aminoethyl)-N-methyl-,
[3-(2-Aminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide,
ACMC-209ytk,
Sumatriptan EP Impurity E,
Sumatriptan succinate specified impurity E [EP],
SCHEMBL5918470,
CTK5G2016,
DTXSID90237424,
MURZXKIEJFJMPP-UHFFFAOYSA-N,
(3-(2-(Aminoethyl))-1H-indol-5-yl)-N-methylmethanesulfonamide,
ACT02651,
ANW-49398,
MFCD08063851,
STL018673,
ZINC22009116,
AKOS015920454,
Sumatriptan impurity, (3-(2-(aminoethyl))-1H-indol-5-yl)-N-methylmethanesulfonamide- [USP],
AJ-80388,
AS-18598,
BR-46651,
Sumatriptan succinate impurity, (3-(2-(aminoethyl))-1H-indol-5-yl)-N-methylmethanesulfonamide- [USP],
AB0027364,
AX8014185,
TC-138143,
4CH-007533,
FT-0659227,
ST24028273,
W9190,
S-3762,
3-(2-aminoethyl)-1H-indole-5-yl-N-methyl methane sulphonamide,
C12H17N3O2S,
CID9813988,
CS-O-08214,
3- -N-methyl-1H-indole-5-methanesulfonamide,
3-(2-Aminoethyl)-N-methyl-1H-indole-5-methane sulfonamide,
3-[2-Aminoethyl]-N-Methyl-1H-Indole-5-Methane sulfonamide,
3-[2-Amino ethyl]-N-Methyl-1H-Indole-5-Methane Sulfonamide,
1-[3-(2-aminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide,